Supplementary Information from Evolutionary Antifragile Therapy Is a Treatment Strategy to Suppress Drug Resistance by Exploiting Dose–Response Convexity

Authors:

Open Access

Publisher website

2 September 2026

other
Published by American Association for Cancer Research (AACR)

DOI:10.1158/0008-5472.33414963

Abstract

No abstract available

Keywords